Nashville · Pre-Seed–Late Stage · 13 people tracked
Also known as MGC VENTURE PARTNERS 2018 GP, LLC · MGP VENTURE FUND III GP, LLC
Find your way into Mountain Group Capital
2,897 people in our graph share verified history with the Mountain Group Capital team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Mountain Group Capital invests in healthcare and technology, deliberately targeting unique, often overlooked segments within these industries rather than mainstream venture opportunities. The firm takes an active, hands-on role in shaping companies from their earliest stages and emphasizes a 'come early, stay late' philosophy. Drawing on its family office roots, it maintains a patient, long-term outlook and positions itself as a reliable partner regardless of how long a company's journey takes.
Source: firm website, verified Sep 15, 2026.
Team · 13 people
from the firm's website & curated & public directories
Founder mafia
2 people who came through Mountain Group Capital went on to found or lead other companies.
What they invest in
from 30 of 38 portfolio companiesHealthtech ×19Biotech ×17Medical Devices ×11Digital Health ×9AI & Machine Learning ×6AgTech ×5FoodTech ×3Hardware ×3
HQs:United States×28
Who they back
founder profiles across 18 portfolio companiesFounding team size:solo founder×122 founders×33 founders×14+ founders×2
Where their founders studiedfrom 14 founders with education data
The University of North Carolina at Chapel Hill ×3Massachusetts Institute of Technology ×2Stanford University ×2Stanford University Graduate School of Business ×2
What their founders studiedfrom 13 founders with field-of-study data
Life Sciences ×5Business & Management ×3Finance & Accounting ×3Economics ×2Engineering ×2
Where their founders worked beforefrom 13 founders with career history
State of Tennessee ×2
Investments · 38 tracked
founders shown can be your intro pathBy year:2026 · 12025 · 12024 · 32023 · 22022 · 22021 · 12020 · 12019 · 12016 · 12015 · 22013 · 116 dated
AN2 Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule drugs from its boron chemistry platform, with a pipeline spanning hematologic diseases, infectious diseases, oncology, and bone disorders.
BiotechHealthtechMenlo Park, US
Joseph S. Zakrzewski(Co-Founder & Director)Eric Easom(Co-Founder, President & CEO)inGeorge H. Talbot(Co-Founder & Senior Clinical Advisor)Michael R.K. (Dickon) Alley(Co-Founder, SVP Research Fellow, Head of Biology)Sanjay Chanda(Chief Development Officer)inLucy O. Day(Chief Financial Officer)in
Co-investorsAdjuvant CapitalBioRock VenturesFlucas VenturesRA CapitalBiotechnology Value FundHatteras Venture Partners
Castle Biosciences develops genomic diagnostic tests that use a patient's molecular biology to inform disease management and treatment decisions.
BiotechDigital HealthHealthtechFriendswood, US
Derek Maetzold(Executive Officer, Director)inDerek J. Maetzold(President, CEO and Director)inFrank Stokes(Chief Financial Officer)inKristen Oelschlager(Chief Operating Officer)inToby Juvenal(Chief Commercial Officer)inHillary Caruso(Chief of Staff)in
Co-investorsBioBritIllumina VenturesSofinnova HealthQuest Partners
Corcept develops cortisol modulators — molecules that regulate cortisol activity at the glucocorticoid receptor — to treat serious diseases across endocrinology, oncology, metabolism, and neurology.
AI & Machine LearningBiotechHealthtechMedical Devices
Joseph K. Belanoff(Chief Executive Officer and President)
Co-investorsLongitude Capital
5Metis is a discovery-stage company developing boron-based molecules for crop protection, running medicinal/discovery chemistry and toxicity testing programs to invent new agricultural active ingredients.
AgTechBiotechNew MaterialsResearch Triangle Park, US
Brian Green(Co-founder, CEO & CSO)inRichard Gianni(Executive Officer)Steve Tuttle(COO & Board Member)in
BoardYogesh Mago(Director)Cindy Smith(Director)Roger Kemble(Director)
Co-investors1855 Capital PartnersOspraie Ag Science
QScout Lab provides rapid, on-farm diagnostic tests for livestock producers to detect diseases and guide treatment decisions.
AgTechMedical Devices
Co-investorsWolfpack Investor NetworkMiddleland Capital
Beverly Hills, US
Brandon Werber(Executive Officer, Director)inEliyahu Ben-Ezra(Executive Officer)Roy Rubin(Director)Asher Leids(Director)
BoardWilliam Su(Director)David Shadpour(Director)
Co-investorsCanvas VenturesHawke VenturesHeadlinePath VenturesStarting Line75 & Sunny+4 more
Neonatal and pediatric family support technology company
HealthtechNashville, US
Christopher Rand(Executive Officer, Director)Curtis Lowery(Director)
BoardEmily Rash(Director)Alex Whitmore(Director)Gerard Hayden, Jr.(Director)Byron Smith(Director)in
Co-investorsSeedToB
Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesNashville, US
Dr. Laden(Co-founder)Christopher Rand(Executive Officer)Vaughn Bryson(Director)Jeff P. Conn(Director)
BoardWilliam Slattery(Director)Howie Furst(Director)in
Co-investorsRelevance VenturesDeerfield Management Company
Nashville-based provider of home and outpatient community-based palliative care for seriously ill patients, acquired by Anthem in 2018.
Digital HealthHealthtechNashville, US
Brad Smith(Executive Officer, Director)Andrew Lasher(Executive Officer)Diane Seloff(Executive Officer)William Anderson(Executive Officer)inWilliam Frist(Director)in
BoardAnn Lamont(Director)in
Co-investorsBlue Venture FundsFrist Cressey VenturesGV (Google Ventures)Lifeforce CapitalOak HC/FTSandbox Industries
Circular Genomics develops a proprietary platform using circular RNA biomarkers to enable early detection and understanding of neurological diseases through blood tests.
AI & Machine LearningBiotechDigital HealthMedical DevicesAlbuquerque, US
Alexander Hafez(Executive Officer, Director, Promoter)inNikolaos Mellios(Director, Promoter)
Co-investorsCottonwood Technology FundTramway Venture Partners
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Co-investorsHEALTHCARE ROYALTY PARTNERSSolasta VenturesHatterasHatteras Venture Partners
Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.
HardwareHealthtechMedical DevicesRaleigh, US
Ravish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)
Co-investorsHatteras Venture PartnersLightstone VenturesAmzak HealthUS Venture Partners
Ethos Systems provides an AI-driven training platform that delivers personalized, role-specific learning content and ties training to performance data for readiness measurement.
AI & Machine LearningDefense TechEdTech
Andrew Powell(Founder)inSasha Seymore(Founder)in
Co-investorsDorm RoomJ4 VenturesMVP VenturesNorwest Venture PartnersTech Square VenturesCubit Capital
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Jay Strum(Executive Officer)Norman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)
Co-investorsLumira VenturesRA CapitalSolasta VenturesHatteras Venture Partners
In The Bowl Animal Health (ITBAH) develops and commercializes antiparasitics and therapeutics for pets by incorporating the drug directly into the pet's daily food to improve compliance and convenience.
BiotechConsumerFoodTechHealthtechNashville, US
Randolph Legg(Chief Executive Officer)inScott Holmstrom, Ph.D.(Chief Scientific Officer)Eric Graves(Director)Jay Ferguson(Executive Officer)Robin Readnour(Director)Diane Hirakawa(Director)
Co-investorsBioBrit
Ironwood Pharmaceuticals is a gastrointestinal (GI) healthcare company focused on developing treatments for GI diseases.
BiotechDigital HealthHealthtechCambridge, US
PETER M. HECHT(Executive Officer, Director)inMARK G. CURRIE(Executive Officer)inHALLEY E. GIBLERT(Executive Officer)THOMAS GRANEY(Executive Officer)THOMAS A. MCCOURT(Executive Officer)in
BoardTERRANCE G. MCGUIRE(Director)
Co-investorsF-Prime CapitalRidgeback CapitalVenrockMaverick VenturesPolaris Partners
Lineagen provides genetic testing and optical genome mapping services for clinical diagnosis and research applications.
BiotechDigital HealthHealthtechMedical DevicesSalt Lake City, US
Gayland Moffat(Executive Officer)Michael S. Paul(Executive Officer, Director)
BoardMichael Fitzgerald(Director)Fred A. Middleton(Director)Mary C. Tanner(Director)Michael Walsh(Director)
Mindera Health develops digital predictive skin analytics technology, described as Dermal Intelligence, aimed at improving health economic outcomes in dermatology.
AI & Machine LearningBiotechDigital HealthMedical DevicesVista, US
Tahir Mahmood(Executive Officer, Director)inPhilippe ` Nore(Executive Officer, Director)
BoardAndrew Offer(Director)inTyler Whitmore(Director)inJoseph C. Cook III(Director)Patrick Rivelli(Director)
Co-investorsScientific Health Development
NuSirt Sciences develops therapies that activate the sirtuin pathway by combining established pharmaceuticals and natural products to treat cardiometabolic conditions of aging and overnutrition, including fatty liver disease (MAFLD/MASH), obesity, type 2 diabetes, and hypertension.
BiotechHealthtechLongevityNashville, US
Michael Zemel(Executive Officer, Director)Barbara Cannon(Executive Officer)Joseph C. Cook, Jr.(Executive Officer, Director)
BoardEric Satz(Director)Vaughn Bryson(Director)Brian Laden(Director)
Co-investorsHatteras Venture Partners
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
BiotechHealthtechMedical DevicesMalvern, US
Ashutosh Chilkoti(Director)Joel Sussman(Executive Officer)Jonathan Mow(Chief Executive Officer)in
BoardJames Barrett(Director)Michael Gutch(Director)Justin Klein(Director)
Co-investorsNew Enterprise Associates (NEA)Hatteras Venture PartnersJohnson & Johnson Innovation – JJDC
PinkDx is a diagnostics company developing tests, led by a leadership team spanning scientific, medical, and business functions.
BiotechDigital HealthFemTechIndianapolis, US
Richard T. Kloos(Chief Medical Officer)inTimothy McMeekan(Co-Founder, Chief Financial Officer, and Chief Business Officer)Giulia Kennedy(Co-Founder and Chief Scientific Officer)Isaac Ro(Director)inRisa Stack(Director)inEric Wang(Executive Officer)
Co-investorsBEVCBlue Venture FundsSandbox Industries
ReVIDA Recovery operates a network of outpatient recovery centers that treat opioid use disorder using Medication Assisted Treatment (MAT) and a multi-disciplinary behavioral healthcare approach.
Digital HealthHealthtechMental HealthNortheast Tennessee, US
Swap Robotics builds 100% electric autonomous robots for utility-scale solar sites, handling vegetation management, solar panel laying during construction, and materials movement.
CleantechClimate TechEnergyRoboticsNashville, US
Matthew Beasley(Executive Officer, Director)Philip Bredesen(Director)inDavid Reagan Farr(Executive Officer, Director)Matthew H. Kisber(Executive Officer, Director)Michael Payne(Executive Officer)inPhilip N. Bredesen(Director)in
Co-investorsManulife Investment Management
TARGAN is an animal agtech systems company that engineers precision technologies for commercial food producers, with a focus on sustainability and animal welfare.
AgTechAI & Machine LearningFoodTechHardwareRaleigh, US
Ramin Karimpour(Founder)in
Co-investorsOval Park CapitalNovaQuest Capital Management, L.L.C.
Value Payment Systems (operating as Catalis) provides payment processing and collection solutions for government agencies and public sector organizations including courts, tax offices, utilities, and child support agencies.
FintechGovTechSaaSNashville, US
Verility builds Fertile-Eyez, an AI-based image analysis and optical sensor platform for point-of-care fertility testing in animals, assessing sperm quality and predicting ovulation phase.
AgTechAI & Machine LearningHardwareHealthtech
Liane Hart(CEO & Co-Founder)inHadi Shafiee(Inventor, Co-Founder, & Technical Advisor)Brian Kopp(CFO & Head of Business Strategy)inScott Baxter(Chief Product Officer)in
Covetrus provides software and pharmacy solutions for veterinary practices, including an integrated platform that manages prescription workflows, online pharmacy storefronts with home delivery, and compounded medication services.
HealthtechMedical DevicesSaaS
Co-investorsHarbor Light Capital PartnersBorealis VenturesClayton Dubilier & RiceHLM Venture PartnersRock Springs CapitalSequoia Heritage+1 more
Vytelle offers an integrated technology platform for cattle producers to accelerate genetic progress and enable individual animal management.
AgTechBiotechFoodTechSaaSLenexa, US
Kerryann Kocher(Executive Officer, Director)inRudy Leemans(Executive Officer)in
BoardDuane Cantrell(outgoing director)inJim Schultz(Director)Robin Readnour(Director)James (Jim) Shafter(outgoing director)
Co-investorsFulcrum Global CapitalKCRise FundSerra Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Angel Eye HealthBorahCerebrotechMiNDERA CorporationNeuroTronikOverdogReactive BioVelo-1
Exits · 5
3 IPOs · 2 acquisitionsAN2 TherapeuticsNASDAQ: ANTXCastle BiosciencesNASDAQ: CSTLCorcept TherapeuticsNASDAQ: CORTAspire Healthacq. by CareMore Health (Anthem)Overdogacq. by Odd Networks
Portfolio news
latest coverage across their companiesCorcept Therapeutics · investing.com · Sep 4, 2026
AN2 Therapeutics · ng.investing.com · Aug 19, 2026
AngelEye Health · aol.com · Aug 11, 2026
Ironwood Pharmaceuticals · marketbeat.com · Aug 11, 2026
Targan · axios.com · Jun 16, 2026
Clearside Biomedical · elevenflo.com · Mar 6, 2026
Airvet · newmarketpitch.com · Jan 12, 2026
NeuroTronik · hatterasvp.com · Jan 9, 2026
Frequently asked questions
- How many investments has Mountain Group Capital made?
- Mountain Group Capital has 38 tracked investments, 5 of which have exited, including 2 dated in the last 24 months.
- What stage does Mountain Group Capital invest at?
- Mountain Group Capital invests at the Pre-Seed, Seed, Late Stage stages.
- What sectors does Mountain Group Capital focus on?
- Mountain Group Capital focuses on AgTech, AI & Machine Learning, Biotech, Digital Health, Energy, Enterprise Software, Healthtech, Medical Devices, SaaS.
- Where is Mountain Group Capital located?
- Mountain Group Capital is headquartered in Nashville, US.
- Who does Mountain Group Capital co-invest with?
- Mountain Group Capital most often shares deals with BioBrit, Hatteras Venture Partners, RA Capital, among 43 tracked co-investors.
Images
Co-investors · 8
Canvas Prime (formerly Canvas Ventures) is an early-stage venture capital firm that invests in AI transforming digital health and fintech, leading Series A and B rounds in companies ready to scale.
FJ Labs is an early-stage investment firm specializing in marketplaces and network-effect businesses, taking an angel-style co-investment approach alongside institutional venture funds worldwide.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
500 Global (formerly 500 Startups) is a venture capital firm whose flagship Silicon Valley strategy backs promising technology companies from pre-seed onward across a range of sectors and geographies.
Presight Capital is the international venture fund of entrepreneur Christian Angermayer, operating as a registered investment adviser that can invest across public and private markets with checks from $500K to $100M+ throughout a company's entire lifecycle from seed to post-IPO. The fund is backed by prominent hedge fund managers and billionaire angels rather than traditional institutional investors, and focuses heavily on controversial frontier science like psychedelics, brain-computer interfaces, and life extension alongside transformative infrastructure bets in undercapitalized global markets.
Race Capital is an early-stage venture fund that invests in companies operating in data, enterprise, infrastructure, and fintech sectors.
L Catterton Growth is the growth investing arm of L Catterton, a consumer-focused private equity group that has made over 300 investments in consumer brands since 1989. The firm manages roughly $40 billion and backs middle-market companies and emerging high-growth consumer businesses; this unit is listed with a London office.
Angel Ventures (AV) is a Mexican venture capital firm investing in early-stage to early-growth companies across Latin America, acting as a lead Series Seed and Series A investor in startups with business models tailored for the Latin American market.
Firms observed investing alongside Mountain Group Capital, from public investor directories. Shared companies are the overlap with Mountain Group Capital's recorded portfolio.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
Cerity Partners Ventures provides Venture Capital as a Service (VCaaS) for corporations, helping them launch and manage venture capital programs and invest in and partner with startups.
The Trendlines Group is an investment firm that develops and invests in innovation-based companies in agrifood technologies and medtech/healthcare, supporting them from seed stage to market with its experience, network, and resources.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.